CCK-2R positive lesions identified by [68Ga]Ga-DOTA-CCK-66 PET/CT in MTC patients could make them eligible for RLT or TAT with 177Lu or 225Ac-labeled DOTA-CCK-66, respectively. Here, CCKBR is linked to medullary thyroid gland carcinoma.